Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Researchers created a standard system to grade hair damage using microscopic images.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

PCOS is linked to low-grade chronic inflammation.

PCOS is linked to chronic low-grade inflammation, but the role of certain infections is unclear.

New dermoscopic criteria accurately diagnose and grade the severity of hair loss in androgenetic alopecia.

Measuring bald patch size can help grade hair loss severity, with photograph-based evaluation being more reliable.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

Children with lower inhibitory control experience more stress when starting third grade.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

Finasteride reduces prostate cancer risk but may increase high-grade cancer risk.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Finasteride reduces prostate cancer risk but may increase high-grade cancer cases.

Finasteride lowers prostate cancer risk but may increase high-grade tumors and sexual side effects.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

Finasteride is effective for hair loss and may help prevent prostate cancer without increasing high-grade cancer risk.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

Finasteride can't be recommended for cancer prevention due to concerns about high-grade cancer risk.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

The hair shedding scale accurately identifies abnormal hair shedding in women with long hair, with grades 5 and 6 indicating excessive shedding.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Mesothelioma of the tunica vaginalis testis is rare, often high-grade, and has a median survival of about 24 months.

Sinclair grading effectively identifies female androgenic alopecia patterns, with Grade III most common.

A new classification for depth control in hair restoration surgery was proposed, dividing it into three grades based on the depth required for successful graft extraction.

Finasteride and dutasteride reduce prostate cancer risk, but finasteride may increase higher-grade cancer risk.

Dutasteride showed some prevention of prostate issues but also had limitations, especially with high-grade tumors.